Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus

New human cytomegalovirus (HCMV) therapies with novel mechanisms of action are needed to treat drug-resistant HCMV that arises during therapy with currently approved agents. 2-Bromo-5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (BDCRB) is an effective anti-HCMV agent with a novel mechanism of ac...

Descripció completa

Dades bibliogràfiques

Publicat a:	Antimicrob Agents Chemother
Autors principals:	Underwood, Mark R., Ferris, Robert G., Selleseth, Dean W., Davis, Michelle G., Drach, John C., Townsend, Leroy B., Biron, Karen K., Boyd, F. Leslie
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2004
Matèries:	Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400548/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105116/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1647-1651.2004
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!